These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 24287510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.
    Bobba RS, Beattie K, Parkinson B, Kumbhare D, Adachi JD.
    Drug Saf; 2006; 29(12):1133-52. PubMed ID: 17147460
    [Abstract] [Full Text] [Related]

  • 5. Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials.
    Dömötör ZR, Vörhendi N, Hanák L, Hegyi P, Kiss S, Csiki E, Szakó L, Párniczky A, Erőss B.
    Front Endocrinol (Lausanne); 2020; 11():573976. PubMed ID: 33240217
    [Abstract] [Full Text] [Related]

  • 6. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN, HORIZON investigators.
    Lancet; 2009 Apr 11; 373(9671):1253-63. PubMed ID: 19362675
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD009144. PubMed ID: 22161446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference.
    Fadda V, Maratea D, Trippoli S, Messori A.
    J Endocrinol Invest; 2015 Feb 07; 38(2):189-92. PubMed ID: 25412945
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Annual Infusion of Zoledronic Acid and Weekly Oral Alendronate in the Treatment of Primary Osteoporosis: A Meta-Analysis.
    Wang Q, Yu Q, Zeng P, Ai W.
    J Clin Pharmacol; 2023 Apr 07; 63(4):455-465. PubMed ID: 36433675
    [Abstract] [Full Text] [Related]

  • 12. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
    Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C.
    Clin Drug Investig; 2013 Feb 07; 33(2):117-22. PubMed ID: 23184667
    [Abstract] [Full Text] [Related]

  • 13. Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases.
    Anastasilakis AD, Goulis DG, Kita M, Avramidis A.
    Hormones (Athens); 2007 Feb 07; 6(3):233-41. PubMed ID: 17724008
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R, Redzepovic J, Wheatley K, Clark OA, Miladinovic B, Glasmacher A, Kumar A, Djulbegovic B.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD003188. PubMed ID: 22592688
    [Abstract] [Full Text] [Related]

  • 15. Long-term use of bisphosphonates in osteoporosis.
    Watts NB, Diab DL.
    J Clin Endocrinol Metab; 2010 Apr 16; 95(4):1555-65. PubMed ID: 20173017
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous zoledronic acid for the treatment of osteoporosis.
    Lewiecki EM.
    Curr Osteoporos Rep; 2008 Mar 16; 6(1):17-23. PubMed ID: 18430396
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.